Comparison Between Two Techniques During Thyroidectomy (Conventional Dissection Technique and Injection of Methylene Blue Dye Into Inferior Thyroid Artery Technique) Regarding Recurrent Laryngeal Nerve Identification and Preservation
RLN
The Identification of Recurrent Laryngeal Nerve by Injection of Methylene Blue Dye Into the Inferior Thyroid Artery in Comparison to The Conventional Technique During Thyroidectomy, Comparative Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the study is to evaluate the value of injection of methylene blue dye into the inferior thyroid artery for the help of the identification and dissection of recurrent laryngeal nerve, so thyroidectomy could be done with fewer complications in comparison to conventional technique
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedFirst Submitted
Initial submission to the registry
July 6, 2025
CompletedFirst Posted
Study publicly available on registry
July 16, 2025
CompletedJuly 16, 2025
May 1, 2025
1.7 years
July 6, 2025
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Easy and fast identification of recurrent laryngeal nerve
Thyroid gland absorbed the dye and got stained blue while the RLN didn't take the dye and appeared as a white structure in the tracheoesophageal groove
Procedure (Time taken for identification of the recurrent laryngeal nerve after delivery of thyroid lobe (in minutes))
Secondary Outcomes (1)
Lower intra-operative blood loss
The duration of the procedure ranging from one to two hours
Study Arms (2)
Methylene blue group
ACTIVE COMPARATORAfter ligation of the superior pole, 0.5-1 ml of sterile methylene blue dye was injected into the inferior thyroid artery. The thyroid tissue absorbed the dye, while the RLN remained unstained, appearing as a white structure in the tracheoesophageal groove. This aided in its early and safe identification, reducing the risk of injury during dissection.
Conventional technique group
NO INTERVENTIONthe RLN was identified based on conventional anatomical landmarks without the use of dye. The nerve was traced along its expected course near the inferior thyroid artery and ligament of Berry
Interventions
After ligation of the superior pole, 0.5-1 ml of sterile methylene blue dye was injected into the inferior thyroid artery. The thyroid tissue absorbed the dye, while the RLN remained unstained, appearing as a white structure in the tracheoesophageal groove. This aided in its early and safe identification, reducing the risk of injury during dissection.
Eligibility Criteria
You may qualify if:
- All patients who present with simple nodular goiter, solitary thyroid nodule, controlled toxic goiter and failed medical treatment with indication for thyroidectomy.
- Patents undergoing primary surgery (not recurrent).
- Patients who are willing to undergo surgery under general anesthesia without any preoperative complications or major diseases.
- Either gender in the age group of 18-60 years
You may not qualify if:
- Previous thyroid surgery.
- Malignant goiter.
- Major cardiac diseases, renal diseases or patients who are unfit for surgery.
- Methylene blue allergies.
- Pregnancy.
- Patients who refuse to participate in the study.
- Presence of any preoperative cord pathology or patients with dysphonia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Abbassia, Egypt
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2025
First Posted
July 16, 2025
Study Start
June 1, 2023
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
July 16, 2025
Record last verified: 2025-05